Acura® electro Pipettes – Ready-to-Use Initial Package

Pipettes

Acura® electro Pipettes – Ready-to-Use Initial Package

28 Jan, 2016

Published over 10 years ago. See the latest and most current information on Pipettes.

The up-graded Acura® electro line includes seven micro models (0.1 to 1000 µL), three macropipettes (0.1 - 10 mL) and eight multichannel instruments (0.1 to 350 µL). Self-teaching, the intuitive control software avoids any complicated programming steps. There are only 4 keys for quick access to Forward - Reverse - Stepper - Dilute - Tactile and Mixing working modes. The Tactile mode enables precise manual monitoring of aspiration and distribution, which simplifies gel loading operation and micro-titration.

Each Acura® electro is supplied as price advantageous initial package containing one electronic pipette, QC certificate, operating instructions, charging stand, power supply, additional battery pack and Qualitips® pipette tips samples. It is the recommended choice when purchasing an Acura® electro for the first time as all charging accessories are included, allowing user to start working right away. Thereafter, additional Acura® electro pipettes can be bought alone and charged on existing station. This flexibility makes the purchase of the Socorex instrument attractive to all budgets.

Each Acura® electro conforms to CE safety guidelines, to EN ISO 8655 and other international standard requirements. Instrument and charging devices are free of hazardous compounds (RoHS). Two-year warranty.

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
FM approval strengthens intelligent fixed gas detection for refineries and petrochemical plants
Explore more Arrow
Pollution Solutions Online
Slurry grant a fossil fuel failure?
Explore more Arrow
Petro Online
Two temperature-programmed analyses, one integrated GC workflow
Explore more Arrow
Chromatography Today
Unlock high-resolution analysis of therapeutic oligonucleotides
Explore more Arrow